MultiValent Biotherapies, Inc. funding
MultiValent Biotherapies, Inc., a biotechnology company based in Los Altos, CA (founded 2025), filed a Form D with the SEC on March 2, 2026 and reported $10M raised. It filed 2 new offerings in this period, totaling $10M.
Amount raised$10M
Offering sizeOpen-ended
Filed with the SECMarch 2, 2026
First saleJanuary 9, 2026
IndustryBiotechnology
SecuritiesEquity, Debt
LocationLos Altos, CA
Founded2025
Entity typeCorporation
Investors so far4
Minimum investment$12.5K
Revenue rangeNo Revenues
View the original Form D on SEC EDGAR ↗ · All rounds filed Mar 2
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| March 2, 2026 | $10M | Open-ended | Equity, Debt |
| February 27, 2026 | $4.4K | $4.4K | Equity |
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology